The impact of three distinct probiotic supplements on the gut microbiota and its metabolites in healthy adults
Beneficial Microbes · 2025
DOI: 10.1163/18762891-bja00096 ↗Kurz gefasst
Randomisierte kontrollierte Studie in der Zeitschrift Beneficial Microbes, 2025. Verfasst von D R Michael und 11 weiteren Autor:innen. Beteiligte Einrichtung: Cultech Limited, Unit 2 Christchurch Road, Baglan Industrial Park, Port Talbot, United Kingdom. Hauptthemen laut MEDLINE: Probiotics, Gastrointestinal Microbiome. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 106 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
The effects of probiotics on the gut microbiota and microbial metabolites in healthy individuals are not well understood. Faecal and serum samples were collected at the start and end of a 3-month, double-blind, placebo-controlled, randomised study with three different probiotic formulations in free-living, healthy adults. The composition of the faecal microbiota and levels of faecal and/or serum short-chain fatty acids (SCFA) and bile acids (BA) were measured and the probiotic formulations were found to impart differing effects including shifts in the composition and structure of the faecal microbiota, enhanced levels of circulating short chain fatty acids such as butyrate and propionate, and elevated levels of sulphated bile acids in faeces. This was in contrast to the outcomes for the placebo population where very little change occurred over the study. These findings demonstrate that probiotic supplementation elicits formulation specific effects and that there are potential benefits for healthy individuals.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Cultech Limited, Unit 2 Christchurch Road, Baglan Industrial Park, Port Talbot, United Kingdom.
- School of Biosciences, Cardiff University, Cardiff, UK.
- MRC Centre for Molecular Bacteriology and Infection, Imperial College London, London, United Kingdom.
- Division of Digestive Diseases, Department of Metabolism, Digestion and Reproduction, Faculty of Medicine, Imperial College London, London, United Kingdom.
- Division of Systems Medicine, Department of Metabolism, Digestion and Reproduction, Faculty of Medicine, Imperial College London, London, United Kingdom.
- Pharmacology based Clinical Trials, Pennington Biomedical Research Center, 6400 Perkins Rd, Baton Rouge, LA 70808, USA.
ORCID-Profile: D R Michael, D A John, N Coates, I Guschina, J A K McDonald, N P Danckert, M A Valdivia-Garcı́a, G Ramanathan, S F Plummer, D Wang, J R Marchesi, B H Mullish
Zitieren
APA
Michael, D. R., John, D. A., Coates, N., Guschina, I., McDonald, J. A. K., Danckert, N. P., Valdivia-Garcı́a, M. A., Ramanathan, G., Plummer, S. F., Wang, D., Marchesi, J. R., & Mullish, B. H. (2025). The impact of three distinct probiotic supplements on the gut microbiota and its metabolites in healthy adults. Beneficial Microbes. https://doi.org/10.1163/18762891-bja00096
Vancouver
Michael DR, John DA, Coates N, Guschina I, McDonald JAK, Danckert NP, et al. The impact of three distinct probiotic supplements on the gut microbiota and its metabolites in healthy adults. Beneficial Microbes. 2025. doi:10.1163/18762891-bja00096
BibTeX
@article{Michael2025,
author = {Michael, D R and John, D A and Coates, N and Guschina, I and McDonald, J A K and Danckert, N P and Valdivia-Garcı́a, M A and Ramanathan, G and Plummer, S F and Wang, D and Marchesi, J R and Mullish, B H},
title = {The impact of three distinct probiotic supplements on the gut microbiota and its metabolites in healthy adults},
journal = {Beneficial Microbes},
year = {2025},
doi = {10.1163/18762891-bja00096}
}
EUVIMED